ANXA2 and cholangiocarcinoma: Studying human CC cell lines, Xing et al. showed that ANXA2 remodels the cytoskeleton of CC cells, augments the expression and polymerization of F-actin and β-tubulin and counteracts cell contact inhibition, leading to increased cell motility and invasiveness [85].